CATECHOL MONOGLYCERYL ETHER CARBAMATES.

DOI: 10.1002/jps.2600521009

Source and publish data:

Journal of Pharmaceutical Sciences p. 955 - 958 (1963)

Update date:2022-08-03

Topics:

Authors:

SWIDINSKY

KERVENSKI

BROWN BROWN

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1002/jps.2600521009

Full text of DOI:10.1002/jps.2600521009

Products guided by the article

Product name:3-(2-Benzyloxy-phenoxy)-2-carbamoyloxy-propanol-⁽¹⁾

Cas No:28066-52-6

R&D Labs maybe for 28066-52-6

Zibo Ocean International Trade Co.,Ltd(expird)

Contact:+86 533 5160706

Address:1117, Hongtai Bld., Songling rd, Zichuan,Zibo,Shandong,China
Luoyang Aoda chemical Co.,Ltd.

Contact:+86-379-67518785 67516588

Address:MiaoWan industry district,YanShi City,Henan,China
Zibo Linzi Darong Fine Chemical Co., Ltd(expird)

Contact:86-532-67773200; 15689126900

Address:Qidu town,Linzi district,Zibo city,Shandong province,China
Dalian Join King Biochemical Tech. Co., Ltd.

Contact:0411 39216206

Address:814 First State Blvd
Shandong LuZhou Amino Acid Co., Ltd

Contact:86-539-2218025

Address:yishui economic and technical development zone zhenxing south road

Relevant to this article

Construction of Benzofuran-3(2 H)-one Scaffolds with a Quaternary Center via Rh/Co Relay Catalyzed C-H Functionalization/Annulation of N-Aryloxyacetamides and Propiolic Acids

Doi:10.1021/acs.orglett.9b00181
(2019)
Asymmetric hydrogenation via capture of active intermediates generated from aza-pinacol rearrangement

Doi:10.1021/ja5075745
(2014)
Total synthesis of vancomycin - Part 2: Retrosynthetic analysis, synthesis of amino acid building blocks and strategy evaluations

Doi:10.1002/(SICI)1521-3765(19990903)5:9<2602::AID-CHEM2602>3.0.CO;2-X
(1999)
Structural requirements for vanA activity of vancomycin analogues

Doi:10.1016/S0040-4020(02)00743-3
(2002)
Pd-catalyzed cascade cyclization by intramolecular heck insertion of an allene-allylic amination sequence: Application to the synthesis of 3,4-fused tricyclic indoles

Doi:10.1021/acs.orglett.5b00973
(2015)
Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders

Doi:10.1016/j.chempr.2020.06.017
(2020)

Article Doi